3-M syndrome: a growth disorder associated with IGF2 silencing.

Murray, P G; Hanson, D; Coulson, T; Stevens, A; Whatmore, A; Poole, R L; Mackay, D J; Black, G C M; Clayton, P E

Murray, P G; Hanson, D; Coulson, T; Stevens, A; Whatmore, A; Poole, R L; Mackay, D J; Black, G C M; Clayton, P E.

Afiliação

Murray PG; Centre for Paediatrics and Child Health, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK Faculty of Medicine, University of Southampton, Southampton, UK Centre for Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 5th Floor Research, Royal Manchester Children's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Ox

Endocr Connect ; 2(4): 225-35, 2013.

Article em En | MEDLINE | ID: mdl-24148222

Palavras-chave

3-M syndrome; CCDC8; CUL7; IGF2; OBSL1; SGA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Endocr Connect Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google